$33.67 Billion in Sales Expected for Walgreens Boots Alliance Inc (WBA) This Quarter
Wall Street analysts expect Walgreens Boots Alliance Inc (NASDAQ:WBA) to post sales of $33.67 billion for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Walgreens Boots Alliance’s earnings, with the highest sales estimate coming in at $34.31 billion and the lowest estimate coming in at $31.92 billion. Walgreens Boots Alliance posted sales of $30.74 billion during the same quarter last year, which would indicate a positive year-over-year growth rate of 9.5%. The company is scheduled to announce its next earnings report on Thursday, January 3rd.
According to Zacks, analysts expect that Walgreens Boots Alliance will report full-year sales of $137.97 billion for the current financial year, with estimates ranging from $134.52 billion to $139.81 billion. For the next financial year, analysts anticipate that the company will report sales of $142.44 billion, with estimates ranging from $138.20 billion to $145.99 billion. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that that provide coverage for Walgreens Boots Alliance.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.45 by $0.03. The firm had revenue of $33.44 billion during the quarter, compared to analysts’ expectations of $33.64 billion. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%.
In other news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Thursday, August 2nd. The shares were sold at an average price of $65.99, for a total value of $180,548.64. Following the completion of the sale, the director now directly owns 10,943 shares in the company, valued at $722,128.57. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 14.80% of the stock is currently owned by insiders.
Institutional investors have recently modified their holdings of the company. BlueMountain Capital Management LLC bought a new position in Walgreens Boots Alliance during the second quarter worth $103,000. CSat Investment Advisory L.P. bought a new position in Walgreens Boots Alliance during the second quarter worth $104,000. Squar Milner Financial Services LLC bought a new position in Walgreens Boots Alliance during the second quarter worth $106,000. Kaizen Advisory LLC increased its position in Walgreens Boots Alliance by 128.6% during the second quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after acquiring an additional 1,083 shares during the period. Finally, Livingston Group Asset Management CO operating as Southport Capital Management bought a new position in Walgreens Boots Alliance during the third quarter worth $154,000. Institutional investors and hedge funds own 61.96% of the company’s stock.
NASDAQ WBA opened at $77.35 on Monday. The company has a quick ratio of 0.38, a current ratio of 0.82 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $73.42 billion, a price-to-earnings ratio of 12.85, a price-to-earnings-growth ratio of 1.21 and a beta of 1.04. Walgreens Boots Alliance has a 12-month low of $59.07 and a 12-month high of $80.68.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Read More: Float
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.